JP2012507020A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507020A5 JP2012507020A5 JP2011533626A JP2011533626A JP2012507020A5 JP 2012507020 A5 JP2012507020 A5 JP 2012507020A5 JP 2011533626 A JP2011533626 A JP 2011533626A JP 2011533626 A JP2011533626 A JP 2011533626A JP 2012507020 A5 JP2012507020 A5 JP 2012507020A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- assay
- fragment
- metabolic syndrome
- copeptin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08168096.9 | 2008-10-31 | ||
| EP08168096 | 2008-10-31 | ||
| PCT/EP2009/007923 WO2010049179A1 (en) | 2008-10-31 | 2009-10-29 | Arginine vasopressin pro-hormone as predictive biomarker for diabetes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015042777A Division JP6055005B2 (ja) | 2008-10-31 | 2015-03-04 | 糖尿病の予測バイオマーカーとしてのアルギニンバソプレシンプロホルモン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012507020A JP2012507020A (ja) | 2012-03-22 |
| JP2012507020A5 true JP2012507020A5 (https=) | 2012-12-06 |
| JP5785086B2 JP5785086B2 (ja) | 2015-09-24 |
Family
ID=40445457
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011533626A Active JP5785086B2 (ja) | 2008-10-31 | 2009-10-29 | 糖尿病の予測バイオマーカーとしてのアルギニンバソプレシンプロホルモン |
| JP2015042777A Active JP6055005B2 (ja) | 2008-10-31 | 2015-03-04 | 糖尿病の予測バイオマーカーとしてのアルギニンバソプレシンプロホルモン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015042777A Active JP6055005B2 (ja) | 2008-10-31 | 2015-03-04 | 糖尿病の予測バイオマーカーとしてのアルギニンバソプレシンプロホルモン |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9116153B2 (https=) |
| EP (2) | EP2356463B1 (https=) |
| JP (2) | JP5785086B2 (https=) |
| CN (3) | CN102317788A (https=) |
| DK (1) | DK3199951T3 (https=) |
| ES (2) | ES2645688T3 (https=) |
| WO (1) | WO2010049179A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10316583A1 (de) | 2003-04-10 | 2004-10-28 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung |
| JP5308328B2 (ja) | 2006-04-04 | 2013-10-09 | シングレックス，インコーポレイテッド | トロポニンの分析のための高感度のシステムおよび方法 |
| US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| DE102006060112A1 (de) * | 2006-12-20 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM |
| WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| US20130149386A1 (en) * | 2011-12-07 | 2013-06-13 | Region Nordjylland | Cd36 as biomarker for steatosis |
| EP2861767A4 (en) * | 2012-06-15 | 2016-07-27 | Nuclea Biotechnologies Inc | PREDICTIVE MARKERS FOR CANCER AND METAL CHANGE SYNDROME |
| JP6196034B2 (ja) | 2012-12-20 | 2017-09-13 | ライオン株式会社 | 高血糖リスク判定用マーカーペプチドおよびその用途 |
| CN103266089A (zh) * | 2013-05-09 | 2013-08-28 | 南京医科大学第一附属医院 | 抗人和肽素单克隆抗体mcco1及其应用 |
| EP3002589A1 (en) * | 2014-10-01 | 2016-04-06 | sphingotec GmbH | A method for stratifying a female subject for hormone replacement therapy |
| AU2020245775B2 (en) * | 2019-03-28 | 2025-07-10 | Lundoch Diagnostics AB | Use of follistatin in type 2 diabetes risk prediction |
| CN113238063A (zh) * | 2021-05-31 | 2021-08-10 | 迈克生物股份有限公司 | Gdf15评估代谢综合征患者进展为心血管疾病的应用 |
| CN113248590B (zh) * | 2021-06-24 | 2021-09-10 | 天津奇云诺德生物医学有限公司 | 一种NT-proBNP蛋白抗原决定簇多肽及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9606016D0 (en) * | 1996-03-22 | 1996-05-22 | Smithkline Beecham Plc | Novel use |
| CA2492475A1 (en) * | 2002-07-16 | 2004-01-22 | Woomera Therapeutics, Inc. | Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| US20050164238A1 (en) * | 2003-09-29 | 2005-07-28 | Biosite, Inc. | Methods and compositions for the diagnosis of sepsis |
| EP1628136A1 (en) * | 2004-08-19 | 2006-02-22 | B.R.A.H.M.S. Aktiengesellschaft | Method of diagnosis of disease using copeptin |
| CA2625744A1 (en) * | 2005-10-11 | 2007-04-19 | Tethys Bioscience, Inc. | Diabetes-associated markers and methods of use thereof |
| CA2667119C (en) * | 2006-10-18 | 2016-04-12 | Axela Inc. | Measuring multiple analytes over a broad range of concentrations using optical diffraction |
| EP2084543B1 (de) * | 2006-10-26 | 2017-10-18 | B.R.A.H.M.S GmbH | Risikostratifizierung des akuten koronarsyndroms mittels fragmenten / teilpeptiden des provasopressins, insbesondere copeptin oder neurophysin ii |
| WO2008128352A1 (en) * | 2007-04-19 | 2008-10-30 | Axela, Inc. | Methods and compositions for signal amplification |
-
2009
- 2009-10-29 EP EP09744978.9A patent/EP2356463B1/en active Active
- 2009-10-29 ES ES09744978.9T patent/ES2645688T3/es active Active
- 2009-10-29 ES ES16205552T patent/ES2772930T3/es active Active
- 2009-10-29 CN CN2009801438824A patent/CN102317788A/zh active Pending
- 2009-10-29 US US13/126,798 patent/US9116153B2/en active Active
- 2009-10-29 EP EP16205552.9A patent/EP3199951B1/en active Active
- 2009-10-29 JP JP2011533626A patent/JP5785086B2/ja active Active
- 2009-10-29 CN CN201310681318.6A patent/CN103713137A/zh active Pending
- 2009-10-29 CN CN201610269547.0A patent/CN106153943B/zh active Active
- 2009-10-29 DK DK16205552.9T patent/DK3199951T3/da active
- 2009-10-29 WO PCT/EP2009/007923 patent/WO2010049179A1/en not_active Ceased
-
2015
- 2015-03-04 JP JP2015042777A patent/JP6055005B2/ja active Active
- 2015-06-25 US US14/750,201 patent/US9952229B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012507020A5 (https=) | ||
| US8647830B2 (en) | Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease | |
| JP6117251B2 (ja) | 慢性閉塞性肺疾患の患者の転帰予測 | |
| Khan et al. | N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients | |
| JP5718981B2 (ja) | 原発性慢性腎臓疾患の進行についての予後バイオマーカー | |
| Emdin et al. | Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure | |
| JP5711131B2 (ja) | 最初の有害事象の予測のためのバイオマーカー | |
| JP6055005B2 (ja) | 糖尿病の予測バイオマーカーとしてのアルギニンバソプレシンプロホルモン | |
| EP1888765A2 (en) | Methods and compositions for the diagnosis of venous thromboembolic disease | |
| CN101173928A (zh) | 鉴别急性呼吸短促的心源性和肺源性病因的装置和方法 | |
| JP2015515630A (ja) | 慢性心不全が疑われる患者における有害事象の予後 | |
| JP2015537208A (ja) | 心不全リスクの予測改善のためのバイオマーカー | |
| WO2010077654A1 (en) | Combined natriuretic peptide assays | |
| CN107064516A (zh) | 用于诊断中风的nt‑原anp和nt‑原bnp | |
| Chen et al. | Increased serum 2-oxoglutarate associated with high myocardial energy expenditure and poor prognosis in chronic heart failure patients | |
| Gandhi et al. | Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure | |
| Breidthardt et al. | The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea | |
| RU2011103526A (ru) | Диагностирование хронической обструктивной болезни легких (хобл) | |
| Chien et al. | Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP | |
| Choi et al. | The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients | |
| WO2024119898A1 (zh) | 血清可溶性st2在制备预测主动脉夹层患者预后产品中的应用及相关预测装置 | |
| CN101600967B (zh) | 和肽素或后叶激素运载蛋白ii在制备急性冠状动脉综合征危险性分级试剂盒的用途 | |
| EP3918343B1 (en) | Method to predict treatment response in patients with nocturnal enuresis | |
| Feola et al. | Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure | |
| WO2026093458A1 (en) | Cmybp-c for the assessment of asymptomatic heart failure |